Oxford’s potential COVID-19 vaccine shows ‘right sort of immune response’: Scientist

Published: Updated:
Read Mode
100% Font Size
1 min read

A leading scientist behind the University of Oxford's potential COVID-19 vaccine said on Wednesday the team has seen the right sort of immune response in trials, which have entered the Phase III clinical stage.

Read the latest updates in our dedicated coronavirus section.

Speaking at a parliamentary hearing, Sarah Gilbert, professor of vaccinology at the university, said the trial has enrolled 8,000 volunteers for the Phase III of its trial into the vaccine, AZD1222, which was licensed to AstraZeneca.

She said she couldn't give a timeline for when the vaccine might be ready as it depends on the results of the trial.

For all the latest headlines follow our Google News channel online or via the app.

Read more:

New pig ‘flu’ virus, G4 strain of H1N1, has human pandemic risk: Chinese research

US coronavirus: California, Texas see record COVID-19 cases, ‘alarming’ one-day surge

‘Very real’ fear that people may never fully recover from coronavirus, scientists say

Top Content Trending